延迟全身[18F]FDG PET/CT显示头颈癌同步放化疗后系统性血管炎症
该研究纳入24例头颈癌患者,在同步放化疗前及化疗后3个月行2小时延迟全身[18F]FDG PET/CT,随访心血管相关事件。结果显示放化疗后多个动脉节段平均靶本比(avgTBRmean)升高,且放疗剂量与血管炎症指标相关;发生心血管事件的患者相对差异更高,但年龄校正后无独立关联。
要点
- 延迟全身[18F]FDG PET/CT可检测头颈癌同步放化疗后的血管炎症。
- 放化疗后颈动脉、锁骨下动脉及腹主动脉下段avgTBRmean显著升高。
- 血管炎症指标与放疗剂量相关,但心血管事件关联经年龄校正后不独立。
核心结论
- 延迟全身[18F]FDG PET/CT可显示头颈癌患者同步放化疗相关的血管炎症,可能作为治疗相关心血管风险的影像生物标志物,但需更大样本验证。
研究设计与样本
- 研究纳入24例头颈癌患者,在同步放化疗前和化疗后3个月行2小时延迟全身[18F]FDG PET/CT,并随访心血管相关事件。
主要发现
- 放化疗后所有动脉节段avgTBRmean均升高,颈动脉(左:1.32 vs 1.20,P < 0.001;右:1.34 vs 1.24,P = 0.018)、锁骨下动脉(左:1.20 vs 1.14,P = 0.022;右:1.18 vs 1.10,P = 0.019)及腹主动脉下段(1.08 vs 0.96,P < 0.001)升高显著。
- 平均放疗剂量与放化疗后avgTBRmean(r = 0.289,P = 0.002)及RD-avgTBRmean(r = 0.251,P = 0.008)相关。
- 发生心血管事件的患者基于患者的平均RD-avgTBRmean更高(12.1% ± 6.7% vs. 4.5% ± 6.5%,P = 0.032),但年龄校正后无独立关联。
- 上腔静脉SUVmean在放化疗前后PET中相当。
临床怎么用
- 对于头颈癌同步放化疗患者,可考虑采用2小时延迟全身[18F]FDG PET/CT评估血管炎症,作为治疗相关心血管风险的潜在影像标志物。
局限性
- 样本量小(24例),心血管事件与血管炎症的关联经年龄校正后不独立,结论需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the feasibility of 2-h-delayed total-body [18F]FDG PET/CT for detecting vascular inflammation after concurrent chemoradiotherapy (CCRT) in head-and-neck-cancer (HNC) patients and to exploratorily assess its association with cardiovascular-related events (CVRE). METHODS: Twenty-four HNC patients underwent 2-h total-body [18F]FDG PET/CT before and 3 months after CCRT and were followed for CVRE. Vascular inflammation was evaluated across eleven arterial segments. Slice-based mean standardized uptake values (SUVmean) were normalized to the superior vena cava (SVC) to derive the target-to-background ratio (TBRmean), and segmental averages (avgTBRmean) were calculated. Pre- and post-CCRT avgTBRmean were compared, and the relative difference (RD-avgTBRmean) was analyzed for association with radiation dose and CVRE. RESULTS: Post-CCRT PET demonstrated increased avgTBRmean in all arterial segments, with significant increases in the carotid arteries (left: 1.32 vs 1.20, P < 0.001; right: 1.34 vs 1.24, P = 0.018), subclavian arteries (left: 1.20 vs 1.14, P = 0.022; right: 1.18 vs 1.10, P = 0.019), and infrarenal abdominal aorta (1.08 vs 0.96, P < 0.001). Mean radiotherapy dose correlated with both post-CCRT avgTBRmean (r = 0.289, P = 0.002) and RD-avgTBRmean (r = 0.251, P = 0.008). Patient-based average RD-avgTBRmean was higher in patients with CVRE (12.1% ± 6.7% vs. 4.5% ± 6.5%, P = 0.032). However, no independent association remained after age adjustment. The SUVmean of SVC was comparable between pre- and post-CCRT PET. CONCLUSION: Delayed total-body [18F]FDG PET/CT demonstrated CCRT-related vascular inflammation in HNC patients, suggesting a potential imaging biomarker of treatment-related cardiovascular risk but warrants validation in larger studies.
引用
- Liu G, Abdelhafez YG, Mehadji B, et al. Delayed total-body [18F]FDG PET/CT demonstrates systemic vascular inflammation after concurrent chemoradiotherapy in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2026. PMID: 42700250. doi:10.1007/s00259-026-08160-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。